Company Name:Intersect ENT Inc.
CEO: Lisa E. Earnhardt

Sector: Healthcare
Industry:Medical Devices

Exchange: NASDAQ Global Market

Country: USA

Description: Intersect ENT Inc is a commercial stage drug-device company engaged in improving the life for patients with ear, nose and throat conditions.


Key numbers

Market Capitalization:667487700
Shares Outstanding: 31515000
Float: 30211949.295
Next Earning Date:2020-02-25
TTm EPS: -1.2848
TTm Dividend Rate:
200 days moving average:23.85
50 days moving average: 18.3
One day percent Change: 1.46



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,